| [1] |
Vaishya R, Khurana V, Patel S, et al. Long-term delivery of protein therapeutics[J]. Expert Opin Drug Deliv, 2015, 12(3):415-440.
|
| [2] |
Vaishya RD, Khurana V, Patel S, et al. Controlled ocular drug delivery with nanomicelles[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2014, 6(5):422-437.
|
| [3] |
Jia H, Guo Y, Song X, et al. Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-alpha/Fc fusion proteins expressed in Pichia pastoris[J]. Microb Cell Fact, 2016, 15(1):209.
|
| [4] |
Czajkowsky DM, Hu J, Shao Z, et al. Fc-fusion proteins: new developments and future perspectives[J]. EMBO Mol Med, 2012, 4(10):1015-1028.
|
| [5] |
Kim D, Jeon H, Ahn S, et al. An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide[J]. J Control Release, 2017, 256:114-120.
|
| [6] |
Li CY, Huang WL, Qian H. Advances in the research of long-acting strategy of insulin and GLP-1 analogs[J]. J China Pharm Univ(中国药科大学学报), 2018, 49(6):660-670.
|
| [7] |
Deyle K, Kong XD, Heinis C. Phage selection of cyclic peptides for application in research and drug development[J]. Acc Chem Res, 2017, 50(8):1866-1874.
|
| [8] |
Kim D, MacConell L, Zhuang D, et al. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes[J]. Diabetes Care, 2007, 30(6):1487-1493.
|
| [9] |
Oh YJ, Lee JW, Seo JY, et al. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model[J]. J Control Release, 2011, 150(1):56-62.
|
| [10] |
Zhang Y, Wischke C, Mittal S, et al. Design of controlled release PLGA microspheres for hydrophobic fenretinide[J]. Mol Pharm, 2016, 13(8):2622-2630.
|
| [11] |
Rosa GD, Iommelli R, La Rotonda MI, et al. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres[J]. J Control Release, 2000, 69(2):283-295.
|
| [12] |
Bae SE, Son JS, Park K, et al. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine[J]. J Control Release, 2009, 133(1):37-43.
|
| [13] |
Casalini T, Rossi F, Lazzari S, et al. Mathematical modeling of PLGA microparticles: from polymer degradation to drug release[J]. Mol Pharm, 2014, 11(11):4036-4048.
|
| [14] |
Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices[J]. Biomaterials, 2000, 21(23):2475-2490.
|
| [15] |
Díaz E, Puerto I, Ribeiro S, et al. The influence of copolymer composition on PLGA/nHA Scaffolds' cytotoxicity and in vitro degradation[J]. Nanomaterials (Basel), 2017, 7(7): 173.
|
| [16] |
Yang S, Yuan W, Jin T. Formulating protein therapeutics into particulate forms[J]. Expert Opin Drug Deliv, 2009, 6(10):1123-1133.
|
| [17] |
Wu JZ, Williams GR, Li HY, et al. Insulin-loaded PLGA microspheres for glucose-responsive release[J]. Drug Deliv, 2017, 24(1):1513-1525.
|
| [18] |
Jain A, Kunduru KR, Basu A, et al. Injectable formulations of poly(lactic acid) and its copolymers in clinical use[J]. Adv Drug Deliv Rev, 2016, 107:213-227.
|
| [19] |
Guo J, Sun X, Yin H, et al. Chitosan microsphere used as an effective system to deliver a linked antigenic peptides vaccine protect mice against acute and chronic toxoplasmosis[J]. Front Cell Infect Microbiol, 2018, 8:163.
|
| [20] |
Mantripragada S. A lipid based depot (DepoFoam? technology) for sustained release drug delivery[J]. Prog Lipid Res, 2002, 41(5):392-406.
|
| [21] |
Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal formulations in clinical use: an updated review[J]. Pharmaceutics, 2017, 9(2): 12.
|
| [22] |
Lewis KA, Goldyn AK, West KW, et al. A single histrelin implant is effective for 2 years for treatment of central precocious puberty[J]. J Pediatr, 2013, 163(4):1214-1216.
|
| [23] |
Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy[J]. N Engl J Med, 2015, 372(10):923-932.
|
| [24] |
Zhao YN, Xu X, Wen N, et al. A drug carrier for sustained Zero-order release of peptide therapeutics[J]. Sci Rep, 2017, 7(1):5524.
|
| [25] |
Jeong JW, McCall JG, Shin G, et al. Wireless optofluidic systems for programmable in vivo Pharmacology and optogenetics[J]. Cell, 2015, 162(3):662-674.
|
| [26] |
Farra R, Sheppard NF, McCabe L, et al. First-in-human testing of a wirelessly controlled drug delivery microchip[J]. Sci Transl Med, 2012, 4(122):122ra121.
|
| [27] |
Parent M, Clarot I, Gibot S, et al. One-week in vivo sustained release of a peptide formulated into in situ forming implants[J]. Int J Pharm, 2017, 521(1/2):357-360.
|
| [28] |
Brodbeck KJ, DesNoyer JR, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer[J]. J Control Release, 1999, 62(3):333-344.
|
| [29] |
Huang LP, Li YN, Du YA, et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy[J]. Nat Commun, 2019, 10(1):4871.
|
| [30] |
Ruel-Gariepy E, Leroux JC. In situ-forming hydrogels—review of temperature-sensitive systems[J]. Eur J Pharm Biopharm, 2004, 58(2):409-426.
|
| [31] |
Agarwal P, Rupenthal ID. Injectable implants for the sustained release of protein and peptide drugs[J]. Drug Discov Today, 2013, 18(7):337-349.
|
| [32] |
Singh NK, Lee DS. In situ gelling pH- and temperature-sensitive biodegradable block copolymer hydrogels for drug delivery[J]. J Control Release, 2014, 193:214-227.
|
| [33] |
Liu Y, Chen X, Li S, et al. Calcitonin-loaded thermosensitive hydrogel for long-term antiosteopenia therapy[J]. ACS Appl Mater Interfaces, 2017, 9(28):23428-23440.
|
| [34] |
Xu YR, Shen Y, Xiong YR, et al. Synthesis, characterization, biodegradability and biocompatibility of a temperature-sensitive PBLA-PEG-PBLA hydrogel as protein delivery system with low critical gelation concentration[J]. Drug Dev Ind Pharm, 2014, 40(9):1264-1275.
|
| [35] |
Feng Z, Zhao J, Li Y, et al. Temperature-responsive in situ nanoparticle hydrogels based on hydrophilic pendant cyclic ether modified PEG-PCL-PEG[J]. Biomater Sci, 2016, 4(10):1493-1502.
|
| [36] |
Lai MC, Chang KC, Hsu SC, et al. In situ gelation of PEG-PLGA-PEG hydrogels containing high loading of hydroxyapatite: in vitro and in vivo characteristics[J]. Biomed Mater, 2014, 9(1):015011.
|
| [37] |
Bobbala S, Tamboli V, McDowell A, et al. Novel injectable pentablock copolymer based thermoresponsive hydrogels for sustained release vaccines[J]. AAPS J, 2016, 18(1):261-269.
|
| [38] |
Wang C, Wang J, Zhang X, et al. In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy[J]. Sci Transl Med, 2018, 10(429):eaan3682.
|
| [39] |
Zhao Y, Cui Z, Liu B, et al. An injectable strong hydrogel for bone reconstruction[J]. Adv Healthc Mater, 2019, 8(17):e1900709.
|
| [40] |
Nguyen NT, Nguyen LV, Tran NM, et al. The effect of oxidation degree and volume ratio of components on properties and applications of in situ cross-linking hydrogels based on chitosan and hyaluronic acid[J]. Mater Sci Eng C Mater Biol Appl, 2019, 103:109670.
|
| [41] |
Criado-Gonzalez M, Corbella L, Senger B, et al. Photoresponsive nanometer-scale iron alginate hydrogels: a study of gel-sol transition using quartz crystal microbalance[J]. Langmuir, 2019, 35(35):11397-11405.
|
| [42] |
Gupta V, Hwang BH, Doshi N, et al. Delivery of exenatide and insulin using mucoadhesive intestinal devices[J]. Ann Biomed Eng, 2016, 44(6):1993-2007.
|
| [43] |
Gupta V, Hwang BH, Lee JH, et al. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin[J]. J Control Release, 2013, 172(3):753-762.
|
| [44] |
Castro PM, Fonte P, Sousa F, et al. Oral films as breakthrough tools for oral delivery of proteins/peptides[J]. J Control Release, 2015, 211:63-73.
|
| [45] |
Salvioni L, Fiandra L, Del CMD, et al. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats[J]. Pharmacol Res, 2016, 110:122-130.
|
| [46] |
Zhao XH, Shan C, Zu YG, et al. Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin[J]. Int J Pharm, 2013, 454(1):278-284.
|
| [47] |
Chuang EY, Lin KJ, Lin PY, et al. Self-assembling bubble carriers for oral protein delivery[J]. Biomaterials, 2015, 64:115-124.
|
| [48] |
Leonaviciute G, Bernkop-Schnurch A. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery[J]. Expert Opin Drug Deliv, 2015, 12(11):1703-1716.
|
| [49] |
Kusamori K, Katsumi H, Sakai R, et al. Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha[J]. Biofabrication, 2016, 8(1):015006.
|
| [50] |
Lau S, Fei J, Liu H, et al. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery[J]. J Control Release, 2017, 265:113-119.
|
| [51] |
van der Maaden K, Heuts J, Camps M, et al. Hollow microneedle-mediated micro-injections of a liposomal HPV E743-63 synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses[J]. J Control Release, 2018, 269:347-354.
|
| [52] |
Qiu YQ, Qin GJ, Zhang SH, et al. Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery[J]. Int J Pharm, 2012, 437(1):51-56.
|
| [53] |
Seong KY, Seo MS, Hwang DY, et al. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin[J]. J Control Release, 2017, 265:48-56.
|
| [54] |
Chen MC, Huang SF, Lai KY, et al. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination[J]. Biomaterials, 2013, 34(12):3077-3086.
|
| [55] |
Kim MY, Jung BK, Park JH. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin[J]. Biomaterials, 2012, 33(2):668-678.
|
| [56] |
Ganesan P, Choi DK. Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy[J]. Int J Nanomedicine, 2016, 11:1987-2007.
|
| [57] |
Wu PS, Li YS, Kuo YC, et al. Preparation and evaluation of novel transfersomes combined with the natural antioxidant resveratrol[J]. Molecules, 2019, 24(3):600.
|
| [58] |
Carter P, Narasimhan B, Wang Q. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases[J]. Int J Pharm, 2019, 555:49-62.
|
| [59] |
Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery[J]. Mol Membr Biol, 2010, 27(7):247-259.
|
百度学术
下载:
